Galmed Pharmaceuticals Ltd. buy Piper Sandler
Start price
09.05.25
/
50%
€6.40
Target price
09.05.26
€71.34
Performance (%)
-
End price
10.05.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -2,49 % | 0,32 % | 0,75 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % | 32,09 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % | 50,00 % |
| iShares S&P 500 | -2,20 % | 2,00 % | 22,60 % |
Comments by Piper_Sandler for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target lowered by analysts at Piper Sandler from $100.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Stopped prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€93.31
06.11.25
06.11.25
-
07.11.25
07.11.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.37
20.05.24
20.05.24
€73.65
20.05.25
20.05.25
1648.63%
21.05.25
21.05.25

